Combining Meds Is Best

Published Online: Wednesday, March 1, 2006

A combination of therapies for the relief of rheumatoid arthritis (RA) was found to have a greater effect than either therapy alone, as reported in the January 2006 issue of Arthritis & Rheumatism. A 2-year study involved 539 patients who had had active RA for <3 years.

The patients (mean age 52) were divided into 3 groups: one group received methotrexate; another group received injections of adalimumab; and the third group received both treatments. All groups were evaluated at 6, 12, and 24 months.

After 1 year, 62% of those on combination therapy had a 50% improvement in symptoms, compared with 41% of the adalimumab group and 46% of the methotrexate group. At 2 years, nearly half of the patients on combination therapy exhibited major clinical remission—about twice as many as either of the other groups.

Latest Articles
Having trouble getting your hands on FluMist?
Novartis is paying $390 million to settle charges that it paid kickbacks to pharmacies to encourage drug sales.
Anxiety sensitivity has been linked to more debilitating asthma symptoms and greater functional limitations.
Nasal corticosteroid sprays do not seem to be viable treatments for the common cold.
Latest Issues